Valvular & structural heart disease
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry
Authors' conclusion
This first real-world report of TTVR screening demonstrated a high screening failure rate, mainly related to large tricuspid annular diameter. Patients undergoing TTVR had superior TR reduction and symptom alleviation compared with bailout tricuspid transcatheter edge-to-edge repair, at the cost of greater procedural complications.
Study context
- Population
- Patients with tricuspid regurgitation (TR) screened for transcatheter tricuspid valve replacement (TTVR) at 7 centres on a compassionate-use basisscreened
- Participants
- 149 patients
- Exposure
- TTVR vs bailout tricuspid TEER after failed TTVR screening
- Outcome
- NYHA functional class and TR grade
- Follow-up
- 30-day follow-up
Methodological details7 centres, compassionate use
- 7 centres
- Compassionate use
Main finding
As reported in the abstract
| Group | NYHA I or II | TR ≤1+ |
|---|---|---|
| TTVR | from 21% to 68%; P < 0.001 | 97% (P < 0.001 from baseline) |
| Bailout TEER | from 27% to 58%; P < 0.001 | 43% (P < 0.001 from baseline) |
NYHA I or II
TR ≤1+
Observational data: associations, not effects.
Secondary outcomes
TTVR screening failure rate
- Screening failure rate, mainly large tricuspid annular diameter
- 74%
Technical success
- Technical success
- 91%
All-cause mortality · 30 days
- Mortality
- 8%
HF hospitalization · 30 days
- HF hospitalization
- 5%
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →